RITUXIMAB-PVVR for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 36 adverse event reports in the FDA FAERS database where RITUXIMAB-PVVR was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for RITUXIMAB-PVVR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,079 | 49.4% | 209 | 502 |
| Intentional product use issue | 627 | 14.9% | 56 | 146 |
| Condition aggravated | 514 | 12.2% | 26 | 147 |
| Death | 338 | 8.0% | 338 | 63 |
| Covid-19 | 322 | 7.7% | 39 | 135 |
| Fatigue | 318 | 7.6% | 15 | 84 |
| Dyspnoea | 314 | 7.5% | 27 | 104 |
| Inappropriate schedule of product administration | 311 | 7.4% | 21 | 77 |
| Headache | 291 | 6.9% | 8 | 77 |
| Pruritus | 288 | 6.8% | 4 | 35 |
| Nausea | 286 | 6.8% | 8 | 76 |
| Malaise | 275 | 6.5% | 28 | 95 |
| Pain | 271 | 6.4% | 13 | 79 |
| Throat irritation | 259 | 6.2% | 1 | 30 |
| Cough | 249 | 5.9% | 15 | 64 |
Other Indications for RITUXIMAB-PVVR
Rheumatoid arthritis (1,659)
Granulomatosis with polyangiitis (745)
Microscopic polyangiitis (174)
Multiple sclerosis (106)
Systemic lupus erythematosus (105)
Interstitial lung disease (73)
Glomerulonephritis membranous (65)
Anti-neutrophil cytoplasmic antibody positive vasculitis (62)
Sjogren's syndrome (54)
Product used for unknown indication (52)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)